CAJ | 학술논문

目的：为了进一步提高我院治疗房颤并发脑栓塞的临床疗效，本文就低分子肝素治疗房颤并发脑栓塞的临床效果进行了浅显的研究和探讨。方法选择我院自2012年12月至2013年12月期间收治的房颤并发脑栓塞患者90例，将其平均分为观察组和对照组，均行常规治疗，观察组患者加用低分子肝素治疗，观察和统计两组患者的治疗效果及不良反应发生情况。结果观察组患者的治疗效果明显高于对照组患者（P<0.05）；观察组患者不良反应发生率明显低于对照组患者（P<0.05）。结论低分子肝素治疗房颤并发脑栓塞的临床效果显著，值得推广。
목적：위료진일보제고아원치료방전병발뇌전새적림상료효，본문취저분자간소치료방전병발뇌전새적림상효과진행료천현적연구화탐토。방법선택아원자2012년12월지2013년12월기간수치적방전병발뇌전새환자90례，장기평균분위관찰조화대조조，균행상규치료，관찰조환자가용저분자간소치료，관찰화통계량조환자적치료효과급불량반응발생정황。결과관찰조환자적치료효과명현고우대조조환자（P<0.05）；관찰조환자불량반응발생솔명현저우대조조환자（P<0.05）。결론저분자간소치료방전병발뇌전새적림상효과현저，치득추엄。
Objective: to further improve the clinical curative effect of the treatment of atrial fibril ation complicated with cerebral embolism, this paper do a simple research on the clinical effect of low molecular weight heparin in treatment of cerebral embolism in patients with atrial fibril ation. Methods: in our hospital from 90 patients with atrial fibril ation complicated with cerebralembolization from 2012 December to 2013 December period, the average divided into observation group and control group, both groups received conventional treatment, the observation group were treated with low molecular weight heparin therapy, the treatment effect and adverse reactions of two groups were observed and statistics. Results: the observation group patientswas significantly higher than that of patients in control group (P< 0.05); the patients in observation group the incidence of adverse reaction was lower than that of the control group patients (P< 0.05). Conclusion: the clinical effect oflow molecular heparin in the treatment of atrial fibril ation complicating cerebral embolism is significant, worthy of promotion.